MOWOOT’s Post

Update on latest research, rare liver disease management, use of AI in clinical practice... what are YOUR educational needs. Tell us about it and help us shape next year's #EASLcongress 2025.

𝐒𝐡𝐚𝐩𝐢𝐧𝐠 𝐚 𝐁𝐫𝐢𝐠𝐡𝐭𝐞𝐫 𝐅𝐮𝐭𝐮𝐫𝐞 𝐟𝐨𝐫 𝐄𝐨𝐄 𝐏𝐚𝐭𝐢𝐞𝐧𝐭𝐬: 𝐏𝐚𝐬𝐬𝐢𝐨𝐧, 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧, 𝐚𝐧𝐝 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐚𝐭 𝐔𝐄𝐆 𝐖𝐞𝐞𝐤 𝐢𝐧 𝐕𝐢𝐞𝐧𝐧𝐚 🌟 The future is bright as we continue to make strides in understanding and treating eosinophilic esophagitis (EoE). This week at the UEG - United European Gastroenterology meeting in Vienna, We are eager to engage with fellow gastroenterologists, dive into the latest scientific publications, and explore the new possibilities these discoveries hold. Together, we’re shaping a future where personalized care and innovative treatments will make a lasting impact on patients’ lives. Let’s learn, share, and push the boundaries of gastroenterology! #EoE #Gastroenterology #UEGWeek #InnovationInMedicine #PersonalizedCare #MedicalResearch #FutureOfHealthcare”

🎉 Today, we presented the clinical outcomes of 100 cases using HOPE via ECMO in liver transplant grafts from patients at a Chilean public hospital at the ALEH Congress in Santiago, Chile. 🔬 This technique not only provides an efficient alternative for graft management but also offers the potential to reduce the costs associated with traditional perfusion machines. 📊 Our results are consistent with what has been reported in the literature, and we hope that sharing this work will help break down barriers for other countries like ours, which face financial constraints. 💡 Of the 100 grafts, 16 were extended criteria donors, showing good outcomes that align with clinical trials, but in our case, we used ECMO. 📝 This was an observational study, with all the limitations that come with it, but we are eager to move towards more robust research to further validate our findings. 👏 A special recognition to medical intern Francisca Martínez, who presented the work excellently. We continue to innovate and optimize resources in transplant medicine. A big thank you to the entire team for this achievement! #LiverTransplantation #Research #ECMO #HOPE #ALEH #HealthcareInnovation #Collaboration

 I am glad to share the publication of another article (the first from #InterdisziplinäreIntensivmedizin @#KlinikumBamberg in cooperation with the #PSPH @#MAHE) in a series of studies that use omics research in sepsis as an empirical unit of analysis to explore the distribution patterns, funding characteristics, collaborations, and trends of convergence and divergence of research activities among (Supra)national entities.  https://lnkd.in/eH9xK4R3

🎞 Watch the Amazing Highlights of the most recent Precision in Clinical Trials #PCTSUMMIT & Precision in Medical Devices #PMDSUMMIT that recently happened at the Hilton Boston Park Plaza on May 6th-7th, 2024. Link to Watch ➡ : https://lnkd.in/eRYsJi3u This #Summit brought together numerous #Biopharma leaders that discussed the recent wave of #Innovation that is coming to the #ClinicalTrials and #DrugDevelopment industry in 2024 and beyond. Email us at info@Precision-Globe.com to learn about our upcoming #LifeSciences Events, you can also learn more by visiting the link below: 📲 https://lnkd.in/ecp62Jy #DigitalHealth #EastCoast #LifeSciences #ClinicalDevelopment #CRO #ClinicalOperations #AI #ML #Datamanagement #Biostats #MedTech #MedicalDevices #Pharma #Biotech #Diagnostics #Therapeutics #Medicine #Patients #Oncology #RareDisease #CNS #Neurology #TherapeuticFocused #PatientRecruitment #Marketing

The 9th Academic Symposium of the Chinese Chapter of the International Hepato-Pancreato-Biliary Association (IHPBA) concluded successfully, marking a significant step forward in global collaboration for HPB health. Hosted by Lanfei Cheng, professors Rene Adam current IHPBA President, and Xiaoping Chen, President of the CCIHPBA, shared insights into advancing HPB diagnosis and treatment worldwide, highlighting China’s growing role in international HPB research and clinical practice. Discussions focused on fostering joint clinical research, expanding educational programs, and strengthening ties with Belt and Road countries to further promote HPB health on a global scale. #IHPBA2024 #HPBSurgery #GlobalCollaboration #MedicalInnovation #HepatoPancreatoBiliary #ChinaInOncology #InternationalMedicine

I am speedy on frankincense, Boswellic Acid Extract and it’s use with chronic diseases

Our Principal Clinical Scientist, Dr. John Connell, attended the American Society for Bone and Mineral Research (ASBMR) 2024 Annual Meeting over the weekend to connect with and learn from global leaders in bone, mineral, and musculoskeletal research.   His key takeaways included:   🔬 The session "Strategy to Advance Bone Mineral Density (BMD) as a Regulatory Endpoint (SABRE) for Clinical Trials" provided exciting updates to those involved in treatment development for bone disorders. Moderators Prof. Mary Bouxsein and Dr. Joy Tsai were joined by speakers Prof. Dennis Black and Dr. Theresa Kehoe, MD and shared how this promising initiative has the potential to significantly accelerate and reduce the cost of osteoporosis clinical trials by using BMD from DEXA scans as the primary clinical endpoint instead of relying on fracture outcomes.   🎓 The "Applying Osteoporosis Guidelines in Clinical Practice: Can We Reach Consensus?" session, moderated by Prof. Ben Leder and featuring esteemed speakers Prof. Robert Wermers, Dr. Andrea Singer, Prof. Clifford Rosen, and Dr. Michael McClung, discussed important clinical perspectives surrounding the current osteoporosis guidelines and how they could be improved.   🌎 Dr. Jotheeswaran Amuthavalli Thiyagarajan, an epidemiologist from the World Health Organization, emphasized the need for collaboration on the new WHO Global Report on Bone Health & Fracture, a topic we're excited to be part of thanks to our ESCEO and #PRECCO membership.   Attending ASBMR, the largest conference of its kind, has provided our team with innumerable insights and will provide valuable input to our development processes.   We look forward to seeing the progress around these important topics at next year's event!   #ASBMR2024 #BoneHealth #Osteoporosis

We appreciate very much at CIBP this Italian research by Dr. Francesco Prattichizzo Ph.D & Co. recently published in the New England Journal of Medicine. This study holds our admiration not only for its findings but also for providing initial substantiated evidence, based on rigorous research, highlighting the convergence between human health and the environment. It is evident globally that our planet's oceans, rivers, and seas are increasingly contaminated with micro and nano plastics of various compositions. Medical convergence extends beyond intra-sectorial boundaries, such as cardiovascular and digital health, and more emphasis should be put in the interconnection and interdependence between human health and the environment in which we all live. Access the article here: https://rb.gy/mxopog

Multiple Myeloma study results published in the New England Journal of Medicine (NEJM). A huge congratulations to Dr Hanlon Sia and Pindara Private Hospital Clinical Trials & Research Unit on their involvement in the DREAMM-7 and DREAMM-8 Trials. These pivotal studies evaluated the efficacy and safety of alternative treatments for patients with relapsed or refractory multiple myeloma. The results demonstrate significant improvement in patient outcomes, supporting the potential for robust new treatment options. NEJM is the most widely read, cited and influential general medical journal globally, and highlights the exceptional impact of these publications. This is a considerable step forward in patient care, and an incredible achievement for Pindara Private Hospital Clinical Trials & Research Unit and the broader study team. Read both papers published in NEJM here: https://lnkd.in/gHvpXbm3   https://lnkd.in/gZBMGGDg #NEJM #ClinicalTrials #RamsayResearch #PindaraPrivateHospital #MultipleMyeloma